GlassScriptPhysician profile
Nicole M Lyons
NPI 1093121600
$7,148.67
in general payments reported to CMS, 2019-2025
15 companies · $3,286 in 2025
The $3,286 reported for 2025 was more than what 97% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $780 · 2023: $1,216 · 2024: $1,590 · 2025: $3,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,598 · Travel and Lodging: $1,390 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,597.61 |
| Travel and Lodging | $1,389.93 |
| Education | $104.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,544.95 | 2025 | Neurostar Tms Therapy System |
| Abbvie INC. | $1,117.39 | 2022-2025 | |
| Alkermes, INC. | $986.72 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Neurocrine Biosciences, INC. | $734.67 | 2023-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $681.80 | 2021-2025 | Invega, Spravato, Invega Sustenna |
| Teva Pharmaceuticals USA, INC. | $590.81 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $576.56 | 2024-2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $269.54 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Abilify Mycite |
| Vanda Pharmaceuticals INC. | $179.99 | 2022-2025 | Fanapt, Hetlioz |
| Idorsia Pharmaceuticals US INC | $171.91 | 2023 | Quviviq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $157.45 | 2021-2025 | Caplyta |
| Indivior INC. | $67.25 | 2022-2024 | Perseris |
| Lundbeck LLC | $33.56 | 2023-2024 | Rexulti |
| Ironshore Pharmaceuticals INC. | $21.21 | 2023 | Jornay Pm |
| Corium, LLC | $14.86 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.